World Journal of Clinical Cases-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=2168901, encodeId=d6e021689019d, content=审稿速度:3.0 | 投稿命中率:75.0 经验分享：比较容易中，小修一次就接受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ec578253286, createdName=ms5000000127745421, createdTime=Thu Nov 16 20:46:10 CST 2023, time=2023-11-16, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=1221311, encodeId=6078122131175, content=审稿速度:12.0 | 投稿命中率:75.0 偏重的研究方向：心血管疾病个案报道 经验分享：垃圾杂志，外审速度极快，1周结果全部回来，1个月后编辑发回修改，然后在科学编辑那滞留了4个月没动静，中间催稿无数次无效，且不给正式接收函，最后找杂志总编辑投诉安排校稿了，然后又经过1个月的强硬催稿才发接收函。投稿应该是相对很容易中的，但是中危预警，版面费又奇高2250美元，医院很可能不给报销。且投稿要求文件很多，准备很麻烦，必须有润色证明，并且达到A级。慎投！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=921d4775210, createdName=doctorsu1101, createdTime=Sat May 21 00:11:09 CST 2022, time=2022-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=908770, encodeId=7ab5908e7084, content=请问是不可以共一吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=127, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4d925444931, createdName=ms8000001517694171, createdTime=Thu Dec 17 08:18:20 CST 2020, time=2020-12-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1206855, encodeId=b1701206855d2, content=上周周末汇版面费，今天发现银行那边收取15美元的手续费，我是该后期补交这个手续费么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=91395727558, createdName=ms8000001964189397, createdTime=Tue Mar 29 11:01:50 CST 2022, time=2022-03-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2147516, encodeId=c332214e51636, content=期刊名称：World Journal of Clinical Cases 影响因子：1.1 JCR分区：Q4 中科院分区：医学4区 小类：医学：内科4区 OPEN ACCESS：不清楚 出版周期：暂无数据 是否综述：否 预警等级：2023年中科院中风险预警（2021年中风险），多地黑名单预警（2023江苏省肿瘤医院中危预警、2023年度北京301医院预警、长江大学中风险预警、2022复旦大学附属华山医院不鼓励投稿预警期刊、上海市第一人民医院预警） 无视预警的单位果断投，每年收几千篇文章，属于比较好中的，速度也快，就是投稿过程比较繁琐，本人3月投的文章，6月底接收，不影响明年毕业~ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e9c968577, createdName=lunasanger, createdTime=Tue Jul 11 19:16:22 CST 2023, time=2023-07-11, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2145331, encodeId=18f421453310f, content=审稿速度:2.0 | 投稿命中率:95.0 偏重的研究方向：病例报道;肿瘤 经验分享：竟然影响因子也有1.1分, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/Random/55971dc507c93968175ce7cc1e177b372a83869f.jpg, createdBy=f63e4754896, createdName=侠胆医心, createdTime=Thu Jun 29 05:40:19 CST 2023, time=2023-06-29, status=1, ipAttribution=香港), GetPortalCommentsPageByObjectIdResponse(id=1059261, encodeId=546f10592612b, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：胃肠 经验分享：6月投，7月大修，9月修回。然后一定要让签署electric copyright,可惜这个electric copyright只发给了第一作者，没有发给通讯作者，然后通讯作者一直接收不到，而第一作者转发给通讯作者的电子版权协议，因为已经点击过，就没办法再点击，然后就一直耽误着，出版社说发了几次了，但始终没有接收到是怎么回事？通讯作者是hotmail的邮箱。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=33f45280010, createdName=1483f2a9m06(暂无昵称), createdTime=Sun Oct 10 21:39:44 CST 2021, time=2021-10-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1184498, encodeId=2504118449814, content=想问一下这个copyright license agreement 要五天之内提交但是并没有提交按钮还是说所有作者只要点击了accept就可以了然后和修改的文章14天之内提交上就好呀谢谢大家, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a3085595427, createdName=ms2000000810824338, createdTime=Sat Jan 15 09:01:15 CST 2022, time=2022-01-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2107181, encodeId=0d7c210e181e0, content=审稿速度:2.0 | 投稿命中率:95.0 偏重的研究方向：肿瘤 经验分享：已接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d8022567422, createdName=12576f0em36暂无昵称, createdTime=Fri Dec 23 18:31:42 CST 2022, time=2022-12-23, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2112349, encodeId=ea04211234942, content=我就想知道有没有被拒稿的😢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=abdf8259299, createdName=ms5000001962513562, createdTime=Tue Jan 31 10:11:43 CST 2023, time=2023-01-31, status=1, ipAttribution=浙江省)]

2023-11-16 ms5000000127745421 来自湖北省

审稿速度:3.0 | 投稿命中率:75.0
经验分享：比较容易中，小修一次就接受

48 0

[GetPortalCommentsPageByObjectIdResponse(id=2168901, encodeId=d6e021689019d, content=审稿速度:3.0 | 投稿命中率:75.0 经验分享：比较容易中，小修一次就接受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ec578253286, createdName=ms5000000127745421, createdTime=Thu Nov 16 20:46:10 CST 2023, time=2023-11-16, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=1221311, encodeId=6078122131175, content=审稿速度:12.0 | 投稿命中率:75.0 偏重的研究方向：心血管疾病个案报道 经验分享：垃圾杂志，外审速度极快，1周结果全部回来，1个月后编辑发回修改，然后在科学编辑那滞留了4个月没动静，中间催稿无数次无效，且不给正式接收函，最后找杂志总编辑投诉安排校稿了，然后又经过1个月的强硬催稿才发接收函。投稿应该是相对很容易中的，但是中危预警，版面费又奇高2250美元，医院很可能不给报销。且投稿要求文件很多，准备很麻烦，必须有润色证明，并且达到A级。慎投！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=921d4775210, createdName=doctorsu1101, createdTime=Sat May 21 00:11:09 CST 2022, time=2022-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=908770, encodeId=7ab5908e7084, content=请问是不可以共一吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=127, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4d925444931, createdName=ms8000001517694171, createdTime=Thu Dec 17 08:18:20 CST 2020, time=2020-12-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1206855, encodeId=b1701206855d2, content=上周周末汇版面费，今天发现银行那边收取15美元的手续费，我是该后期补交这个手续费么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=91395727558, createdName=ms8000001964189397, createdTime=Tue Mar 29 11:01:50 CST 2022, time=2022-03-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2147516, encodeId=c332214e51636, content=期刊名称：World Journal of Clinical Cases 影响因子：1.1 JCR分区：Q4 中科院分区：医学4区 小类：医学：内科4区 OPEN ACCESS：不清楚 出版周期：暂无数据 是否综述：否 预警等级：2023年中科院中风险预警（2021年中风险），多地黑名单预警（2023江苏省肿瘤医院中危预警、2023年度北京301医院预警、长江大学中风险预警、2022复旦大学附属华山医院不鼓励投稿预警期刊、上海市第一人民医院预警） 无视预警的单位果断投，每年收几千篇文章，属于比较好中的，速度也快，就是投稿过程比较繁琐，本人3月投的文章，6月底接收，不影响明年毕业~ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e9c968577, createdName=lunasanger, createdTime=Tue Jul 11 19:16:22 CST 2023, time=2023-07-11, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2145331, encodeId=18f421453310f, content=审稿速度:2.0 | 投稿命中率:95.0 偏重的研究方向：病例报道;肿瘤 经验分享：竟然影响因子也有1.1分, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/Random/55971dc507c93968175ce7cc1e177b372a83869f.jpg, createdBy=f63e4754896, createdName=侠胆医心, createdTime=Thu Jun 29 05:40:19 CST 2023, time=2023-06-29, status=1, ipAttribution=香港), GetPortalCommentsPageByObjectIdResponse(id=1059261, encodeId=546f10592612b, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：胃肠 经验分享：6月投，7月大修，9月修回。然后一定要让签署electric copyright,可惜这个electric copyright只发给了第一作者，没有发给通讯作者，然后通讯作者一直接收不到，而第一作者转发给通讯作者的电子版权协议，因为已经点击过，就没办法再点击，然后就一直耽误着，出版社说发了几次了，但始终没有接收到是怎么回事？通讯作者是hotmail的邮箱。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=33f45280010, createdName=1483f2a9m06(暂无昵称), createdTime=Sun Oct 10 21:39:44 CST 2021, time=2021-10-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1184498, encodeId=2504118449814, content=想问一下这个copyright license agreement 要五天之内提交但是并没有提交按钮还是说所有作者只要点击了accept就可以了然后和修改的文章14天之内提交上就好呀谢谢大家, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a3085595427, createdName=ms2000000810824338, createdTime=Sat Jan 15 09:01:15 CST 2022, time=2022-01-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2107181, encodeId=0d7c210e181e0, content=审稿速度:2.0 | 投稿命中率:95.0 偏重的研究方向：肿瘤 经验分享：已接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d8022567422, createdName=12576f0em36暂无昵称, createdTime=Fri Dec 23 18:31:42 CST 2022, time=2022-12-23, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2112349, encodeId=ea04211234942, content=我就想知道有没有被拒稿的😢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=abdf8259299, createdName=ms5000001962513562, createdTime=Tue Jan 31 10:11:43 CST 2023, time=2023-01-31, status=1, ipAttribution=浙江省)]

2022-05-21 doctorsu1101

审稿速度:12.0 | 投稿命中率:75.0
偏重的研究方向：心血管疾病个案报道
经验分享：垃圾杂志，外审速度极快，1周结果全部回来，1个月后编辑发回修改，然后在科学编辑那滞留了4个月没动静，中间催稿无数次无效，且不给正式接收函，最后找杂志总编辑投诉安排校稿了，然后又经过1个月的强硬催稿才发接收函。投稿应该是相对很容易中的，但是中危预警，版面费又奇高2250美元，医院很可能不给报销。且投稿要求文件很多，准备很麻烦，必须有润色证明，并且达到A级。慎投！

17 6

展开6条回复

[GetPortalCommentsPageByObjectIdResponse(id=2168901, encodeId=d6e021689019d, content=审稿速度:3.0 | 投稿命中率:75.0 经验分享：比较容易中，小修一次就接受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ec578253286, createdName=ms5000000127745421, createdTime=Thu Nov 16 20:46:10 CST 2023, time=2023-11-16, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=1221311, encodeId=6078122131175, content=审稿速度:12.0 | 投稿命中率:75.0 偏重的研究方向：心血管疾病个案报道 经验分享：垃圾杂志，外审速度极快，1周结果全部回来，1个月后编辑发回修改，然后在科学编辑那滞留了4个月没动静，中间催稿无数次无效，且不给正式接收函，最后找杂志总编辑投诉安排校稿了，然后又经过1个月的强硬催稿才发接收函。投稿应该是相对很容易中的，但是中危预警，版面费又奇高2250美元，医院很可能不给报销。且投稿要求文件很多，准备很麻烦，必须有润色证明，并且达到A级。慎投！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=921d4775210, createdName=doctorsu1101, createdTime=Sat May 21 00:11:09 CST 2022, time=2022-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=908770, encodeId=7ab5908e7084, content=请问是不可以共一吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=127, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4d925444931, createdName=ms8000001517694171, createdTime=Thu Dec 17 08:18:20 CST 2020, time=2020-12-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1206855, encodeId=b1701206855d2, content=上周周末汇版面费，今天发现银行那边收取15美元的手续费，我是该后期补交这个手续费么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=91395727558, createdName=ms8000001964189397, createdTime=Tue Mar 29 11:01:50 CST 2022, time=2022-03-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2147516, encodeId=c332214e51636, content=期刊名称：World Journal of Clinical Cases 影响因子：1.1 JCR分区：Q4 中科院分区：医学4区 小类：医学：内科4区 OPEN ACCESS：不清楚 出版周期：暂无数据 是否综述：否 预警等级：2023年中科院中风险预警（2021年中风险），多地黑名单预警（2023江苏省肿瘤医院中危预警、2023年度北京301医院预警、长江大学中风险预警、2022复旦大学附属华山医院不鼓励投稿预警期刊、上海市第一人民医院预警） 无视预警的单位果断投，每年收几千篇文章，属于比较好中的，速度也快，就是投稿过程比较繁琐，本人3月投的文章，6月底接收，不影响明年毕业~ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e9c968577, createdName=lunasanger, createdTime=Tue Jul 11 19:16:22 CST 2023, time=2023-07-11, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2145331, encodeId=18f421453310f, content=审稿速度:2.0 | 投稿命中率:95.0 偏重的研究方向：病例报道;肿瘤 经验分享：竟然影响因子也有1.1分, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/Random/55971dc507c93968175ce7cc1e177b372a83869f.jpg, createdBy=f63e4754896, createdName=侠胆医心, createdTime=Thu Jun 29 05:40:19 CST 2023, time=2023-06-29, status=1, ipAttribution=香港), GetPortalCommentsPageByObjectIdResponse(id=1059261, encodeId=546f10592612b, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：胃肠 经验分享：6月投，7月大修，9月修回。然后一定要让签署electric copyright,可惜这个electric copyright只发给了第一作者，没有发给通讯作者，然后通讯作者一直接收不到，而第一作者转发给通讯作者的电子版权协议，因为已经点击过，就没办法再点击，然后就一直耽误着，出版社说发了几次了，但始终没有接收到是怎么回事？通讯作者是hotmail的邮箱。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=33f45280010, createdName=1483f2a9m06(暂无昵称), createdTime=Sun Oct 10 21:39:44 CST 2021, time=2021-10-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1184498, encodeId=2504118449814, content=想问一下这个copyright license agreement 要五天之内提交但是并没有提交按钮还是说所有作者只要点击了accept就可以了然后和修改的文章14天之内提交上就好呀谢谢大家, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a3085595427, createdName=ms2000000810824338, createdTime=Sat Jan 15 09:01:15 CST 2022, time=2022-01-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2107181, encodeId=0d7c210e181e0, content=审稿速度:2.0 | 投稿命中率:95.0 偏重的研究方向：肿瘤 经验分享：已接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d8022567422, createdName=12576f0em36暂无昵称, createdTime=Fri Dec 23 18:31:42 CST 2022, time=2022-12-23, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2112349, encodeId=ea04211234942, content=我就想知道有没有被拒稿的😢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=abdf8259299, createdName=ms5000001962513562, createdTime=Tue Jan 31 10:11:43 CST 2023, time=2023-01-31, status=1, ipAttribution=浙江省)]

2020-12-17 ms8000001517694171

请问是不可以共一吗？

127 4

展开4条回复

[GetPortalCommentsPageByObjectIdResponse(id=2168901, encodeId=d6e021689019d, content=审稿速度:3.0 | 投稿命中率:75.0 经验分享：比较容易中，小修一次就接受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ec578253286, createdName=ms5000000127745421, createdTime=Thu Nov 16 20:46:10 CST 2023, time=2023-11-16, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=1221311, encodeId=6078122131175, content=审稿速度:12.0 | 投稿命中率:75.0 偏重的研究方向：心血管疾病个案报道 经验分享：垃圾杂志，外审速度极快，1周结果全部回来，1个月后编辑发回修改，然后在科学编辑那滞留了4个月没动静，中间催稿无数次无效，且不给正式接收函，最后找杂志总编辑投诉安排校稿了，然后又经过1个月的强硬催稿才发接收函。投稿应该是相对很容易中的，但是中危预警，版面费又奇高2250美元，医院很可能不给报销。且投稿要求文件很多，准备很麻烦，必须有润色证明，并且达到A级。慎投！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=921d4775210, createdName=doctorsu1101, createdTime=Sat May 21 00:11:09 CST 2022, time=2022-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=908770, encodeId=7ab5908e7084, content=请问是不可以共一吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=127, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4d925444931, createdName=ms8000001517694171, createdTime=Thu Dec 17 08:18:20 CST 2020, time=2020-12-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1206855, encodeId=b1701206855d2, content=上周周末汇版面费，今天发现银行那边收取15美元的手续费，我是该后期补交这个手续费么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=91395727558, createdName=ms8000001964189397, createdTime=Tue Mar 29 11:01:50 CST 2022, time=2022-03-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2147516, encodeId=c332214e51636, content=期刊名称：World Journal of Clinical Cases 影响因子：1.1 JCR分区：Q4 中科院分区：医学4区 小类：医学：内科4区 OPEN ACCESS：不清楚 出版周期：暂无数据 是否综述：否 预警等级：2023年中科院中风险预警（2021年中风险），多地黑名单预警（2023江苏省肿瘤医院中危预警、2023年度北京301医院预警、长江大学中风险预警、2022复旦大学附属华山医院不鼓励投稿预警期刊、上海市第一人民医院预警） 无视预警的单位果断投，每年收几千篇文章，属于比较好中的，速度也快，就是投稿过程比较繁琐，本人3月投的文章，6月底接收，不影响明年毕业~ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e9c968577, createdName=lunasanger, createdTime=Tue Jul 11 19:16:22 CST 2023, time=2023-07-11, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2145331, encodeId=18f421453310f, content=审稿速度:2.0 | 投稿命中率:95.0 偏重的研究方向：病例报道;肿瘤 经验分享：竟然影响因子也有1.1分, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/Random/55971dc507c93968175ce7cc1e177b372a83869f.jpg, createdBy=f63e4754896, createdName=侠胆医心, createdTime=Thu Jun 29 05:40:19 CST 2023, time=2023-06-29, status=1, ipAttribution=香港), GetPortalCommentsPageByObjectIdResponse(id=1059261, encodeId=546f10592612b, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：胃肠 经验分享：6月投，7月大修，9月修回。然后一定要让签署electric copyright,可惜这个electric copyright只发给了第一作者，没有发给通讯作者，然后通讯作者一直接收不到，而第一作者转发给通讯作者的电子版权协议，因为已经点击过，就没办法再点击，然后就一直耽误着，出版社说发了几次了，但始终没有接收到是怎么回事？通讯作者是hotmail的邮箱。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=33f45280010, createdName=1483f2a9m06(暂无昵称), createdTime=Sun Oct 10 21:39:44 CST 2021, time=2021-10-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1184498, encodeId=2504118449814, content=想问一下这个copyright license agreement 要五天之内提交但是并没有提交按钮还是说所有作者只要点击了accept就可以了然后和修改的文章14天之内提交上就好呀谢谢大家, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a3085595427, createdName=ms2000000810824338, createdTime=Sat Jan 15 09:01:15 CST 2022, time=2022-01-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2107181, encodeId=0d7c210e181e0, content=审稿速度:2.0 | 投稿命中率:95.0 偏重的研究方向：肿瘤 经验分享：已接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d8022567422, createdName=12576f0em36暂无昵称, createdTime=Fri Dec 23 18:31:42 CST 2022, time=2022-12-23, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2112349, encodeId=ea04211234942, content=我就想知道有没有被拒稿的😢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=abdf8259299, createdName=ms5000001962513562, createdTime=Tue Jan 31 10:11:43 CST 2023, time=2023-01-31, status=1, ipAttribution=浙江省)]

2022-03-29 ms8000001964189397

上周周末汇版面费，今天发现银行那边收取15美元的手续费，我是该后期补交这个手续费么？

71 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2168901, encodeId=d6e021689019d, content=审稿速度:3.0 | 投稿命中率:75.0 经验分享：比较容易中，小修一次就接受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ec578253286, createdName=ms5000000127745421, createdTime=Thu Nov 16 20:46:10 CST 2023, time=2023-11-16, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=1221311, encodeId=6078122131175, content=审稿速度:12.0 | 投稿命中率:75.0 偏重的研究方向：心血管疾病个案报道 经验分享：垃圾杂志，外审速度极快，1周结果全部回来，1个月后编辑发回修改，然后在科学编辑那滞留了4个月没动静，中间催稿无数次无效，且不给正式接收函，最后找杂志总编辑投诉安排校稿了，然后又经过1个月的强硬催稿才发接收函。投稿应该是相对很容易中的，但是中危预警，版面费又奇高2250美元，医院很可能不给报销。且投稿要求文件很多，准备很麻烦，必须有润色证明，并且达到A级。慎投！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=921d4775210, createdName=doctorsu1101, createdTime=Sat May 21 00:11:09 CST 2022, time=2022-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=908770, encodeId=7ab5908e7084, content=请问是不可以共一吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=127, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4d925444931, createdName=ms8000001517694171, createdTime=Thu Dec 17 08:18:20 CST 2020, time=2020-12-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1206855, encodeId=b1701206855d2, content=上周周末汇版面费，今天发现银行那边收取15美元的手续费，我是该后期补交这个手续费么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=91395727558, createdName=ms8000001964189397, createdTime=Tue Mar 29 11:01:50 CST 2022, time=2022-03-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2147516, encodeId=c332214e51636, content=期刊名称：World Journal of Clinical Cases 影响因子：1.1 JCR分区：Q4 中科院分区：医学4区 小类：医学：内科4区 OPEN ACCESS：不清楚 出版周期：暂无数据 是否综述：否 预警等级：2023年中科院中风险预警（2021年中风险），多地黑名单预警（2023江苏省肿瘤医院中危预警、2023年度北京301医院预警、长江大学中风险预警、2022复旦大学附属华山医院不鼓励投稿预警期刊、上海市第一人民医院预警） 无视预警的单位果断投，每年收几千篇文章，属于比较好中的，速度也快，就是投稿过程比较繁琐，本人3月投的文章，6月底接收，不影响明年毕业~ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e9c968577, createdName=lunasanger, createdTime=Tue Jul 11 19:16:22 CST 2023, time=2023-07-11, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2145331, encodeId=18f421453310f, content=审稿速度:2.0 | 投稿命中率:95.0 偏重的研究方向：病例报道;肿瘤 经验分享：竟然影响因子也有1.1分, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/Random/55971dc507c93968175ce7cc1e177b372a83869f.jpg, createdBy=f63e4754896, createdName=侠胆医心, createdTime=Thu Jun 29 05:40:19 CST 2023, time=2023-06-29, status=1, ipAttribution=香港), GetPortalCommentsPageByObjectIdResponse(id=1059261, encodeId=546f10592612b, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：胃肠 经验分享：6月投，7月大修，9月修回。然后一定要让签署electric copyright,可惜这个electric copyright只发给了第一作者，没有发给通讯作者，然后通讯作者一直接收不到，而第一作者转发给通讯作者的电子版权协议，因为已经点击过，就没办法再点击，然后就一直耽误着，出版社说发了几次了，但始终没有接收到是怎么回事？通讯作者是hotmail的邮箱。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=33f45280010, createdName=1483f2a9m06(暂无昵称), createdTime=Sun Oct 10 21:39:44 CST 2021, time=2021-10-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1184498, encodeId=2504118449814, content=想问一下这个copyright license agreement 要五天之内提交但是并没有提交按钮还是说所有作者只要点击了accept就可以了然后和修改的文章14天之内提交上就好呀谢谢大家, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a3085595427, createdName=ms2000000810824338, createdTime=Sat Jan 15 09:01:15 CST 2022, time=2022-01-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2107181, encodeId=0d7c210e181e0, content=审稿速度:2.0 | 投稿命中率:95.0 偏重的研究方向：肿瘤 经验分享：已接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d8022567422, createdName=12576f0em36暂无昵称, createdTime=Fri Dec 23 18:31:42 CST 2022, time=2022-12-23, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2112349, encodeId=ea04211234942, content=我就想知道有没有被拒稿的😢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=abdf8259299, createdName=ms5000001962513562, createdTime=Tue Jan 31 10:11:43 CST 2023, time=2023-01-31, status=1, ipAttribution=浙江省)]

2023-07-11 lunasanger 来自上海

期刊名称：World Journal of Clinical Cases
影响因子：1.1
JCR分区：Q4
中科院分区：医学4区
小类：医学：内科4区
OPEN ACCESS：不清楚
出版周期：暂无数据
是否综述：否
预警等级：2023年中科院中风险预警（2021年中风险），多地黑名单预警（2023江苏省肿瘤医院中危预警、2023年度北京301医院预警、长江大学中风险预警、2022复旦大学附属华山医院不鼓励投稿预警期刊、上海市第一人民医院预警）
无视预警的单位果断投，每年收几千篇文章，属于比较好中的，速度也快，就是投稿过程比较繁琐，本人3月投的文章，6月底接收，不影响明年毕业~

73 0

[GetPortalCommentsPageByObjectIdResponse(id=2168901, encodeId=d6e021689019d, content=审稿速度:3.0 | 投稿命中率:75.0 经验分享：比较容易中，小修一次就接受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ec578253286, createdName=ms5000000127745421, createdTime=Thu Nov 16 20:46:10 CST 2023, time=2023-11-16, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=1221311, encodeId=6078122131175, content=审稿速度:12.0 | 投稿命中率:75.0 偏重的研究方向：心血管疾病个案报道 经验分享：垃圾杂志，外审速度极快，1周结果全部回来，1个月后编辑发回修改，然后在科学编辑那滞留了4个月没动静，中间催稿无数次无效，且不给正式接收函，最后找杂志总编辑投诉安排校稿了，然后又经过1个月的强硬催稿才发接收函。投稿应该是相对很容易中的，但是中危预警，版面费又奇高2250美元，医院很可能不给报销。且投稿要求文件很多，准备很麻烦，必须有润色证明，并且达到A级。慎投！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=921d4775210, createdName=doctorsu1101, createdTime=Sat May 21 00:11:09 CST 2022, time=2022-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=908770, encodeId=7ab5908e7084, content=请问是不可以共一吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=127, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4d925444931, createdName=ms8000001517694171, createdTime=Thu Dec 17 08:18:20 CST 2020, time=2020-12-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1206855, encodeId=b1701206855d2, content=上周周末汇版面费，今天发现银行那边收取15美元的手续费，我是该后期补交这个手续费么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=91395727558, createdName=ms8000001964189397, createdTime=Tue Mar 29 11:01:50 CST 2022, time=2022-03-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2147516, encodeId=c332214e51636, content=期刊名称：World Journal of Clinical Cases 影响因子：1.1 JCR分区：Q4 中科院分区：医学4区 小类：医学：内科4区 OPEN ACCESS：不清楚 出版周期：暂无数据 是否综述：否 预警等级：2023年中科院中风险预警（2021年中风险），多地黑名单预警（2023江苏省肿瘤医院中危预警、2023年度北京301医院预警、长江大学中风险预警、2022复旦大学附属华山医院不鼓励投稿预警期刊、上海市第一人民医院预警） 无视预警的单位果断投，每年收几千篇文章，属于比较好中的，速度也快，就是投稿过程比较繁琐，本人3月投的文章，6月底接收，不影响明年毕业~ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e9c968577, createdName=lunasanger, createdTime=Tue Jul 11 19:16:22 CST 2023, time=2023-07-11, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2145331, encodeId=18f421453310f, content=审稿速度:2.0 | 投稿命中率:95.0 偏重的研究方向：病例报道;肿瘤 经验分享：竟然影响因子也有1.1分, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/Random/55971dc507c93968175ce7cc1e177b372a83869f.jpg, createdBy=f63e4754896, createdName=侠胆医心, createdTime=Thu Jun 29 05:40:19 CST 2023, time=2023-06-29, status=1, ipAttribution=香港), GetPortalCommentsPageByObjectIdResponse(id=1059261, encodeId=546f10592612b, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：胃肠 经验分享：6月投，7月大修，9月修回。然后一定要让签署electric copyright,可惜这个electric copyright只发给了第一作者，没有发给通讯作者，然后通讯作者一直接收不到，而第一作者转发给通讯作者的电子版权协议，因为已经点击过，就没办法再点击，然后就一直耽误着，出版社说发了几次了，但始终没有接收到是怎么回事？通讯作者是hotmail的邮箱。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=33f45280010, createdName=1483f2a9m06(暂无昵称), createdTime=Sun Oct 10 21:39:44 CST 2021, time=2021-10-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1184498, encodeId=2504118449814, content=想问一下这个copyright license agreement 要五天之内提交但是并没有提交按钮还是说所有作者只要点击了accept就可以了然后和修改的文章14天之内提交上就好呀谢谢大家, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a3085595427, createdName=ms2000000810824338, createdTime=Sat Jan 15 09:01:15 CST 2022, time=2022-01-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2107181, encodeId=0d7c210e181e0, content=审稿速度:2.0 | 投稿命中率:95.0 偏重的研究方向：肿瘤 经验分享：已接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d8022567422, createdName=12576f0em36暂无昵称, createdTime=Fri Dec 23 18:31:42 CST 2022, time=2022-12-23, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2112349, encodeId=ea04211234942, content=我就想知道有没有被拒稿的😢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=abdf8259299, createdName=ms5000001962513562, createdTime=Tue Jan 31 10:11:43 CST 2023, time=2023-01-31, status=1, ipAttribution=浙江省)]

2023-06-29 侠胆医心来自香港

审稿速度:2.0 | 投稿命中率:95.0
偏重的研究方向：病例报道;肿瘤
经验分享：竟然影响因子也有1.1分

55 0

[GetPortalCommentsPageByObjectIdResponse(id=2168901, encodeId=d6e021689019d, content=审稿速度:3.0 | 投稿命中率:75.0 经验分享：比较容易中，小修一次就接受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ec578253286, createdName=ms5000000127745421, createdTime=Thu Nov 16 20:46:10 CST 2023, time=2023-11-16, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=1221311, encodeId=6078122131175, content=审稿速度:12.0 | 投稿命中率:75.0 偏重的研究方向：心血管疾病个案报道 经验分享：垃圾杂志，外审速度极快，1周结果全部回来，1个月后编辑发回修改，然后在科学编辑那滞留了4个月没动静，中间催稿无数次无效，且不给正式接收函，最后找杂志总编辑投诉安排校稿了，然后又经过1个月的强硬催稿才发接收函。投稿应该是相对很容易中的，但是中危预警，版面费又奇高2250美元，医院很可能不给报销。且投稿要求文件很多，准备很麻烦，必须有润色证明，并且达到A级。慎投！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=921d4775210, createdName=doctorsu1101, createdTime=Sat May 21 00:11:09 CST 2022, time=2022-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=908770, encodeId=7ab5908e7084, content=请问是不可以共一吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=127, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4d925444931, createdName=ms8000001517694171, createdTime=Thu Dec 17 08:18:20 CST 2020, time=2020-12-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1206855, encodeId=b1701206855d2, content=上周周末汇版面费，今天发现银行那边收取15美元的手续费，我是该后期补交这个手续费么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=91395727558, createdName=ms8000001964189397, createdTime=Tue Mar 29 11:01:50 CST 2022, time=2022-03-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2147516, encodeId=c332214e51636, content=期刊名称：World Journal of Clinical Cases 影响因子：1.1 JCR分区：Q4 中科院分区：医学4区 小类：医学：内科4区 OPEN ACCESS：不清楚 出版周期：暂无数据 是否综述：否 预警等级：2023年中科院中风险预警（2021年中风险），多地黑名单预警（2023江苏省肿瘤医院中危预警、2023年度北京301医院预警、长江大学中风险预警、2022复旦大学附属华山医院不鼓励投稿预警期刊、上海市第一人民医院预警） 无视预警的单位果断投，每年收几千篇文章，属于比较好中的，速度也快，就是投稿过程比较繁琐，本人3月投的文章，6月底接收，不影响明年毕业~ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e9c968577, createdName=lunasanger, createdTime=Tue Jul 11 19:16:22 CST 2023, time=2023-07-11, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2145331, encodeId=18f421453310f, content=审稿速度:2.0 | 投稿命中率:95.0 偏重的研究方向：病例报道;肿瘤 经验分享：竟然影响因子也有1.1分, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/Random/55971dc507c93968175ce7cc1e177b372a83869f.jpg, createdBy=f63e4754896, createdName=侠胆医心, createdTime=Thu Jun 29 05:40:19 CST 2023, time=2023-06-29, status=1, ipAttribution=香港), GetPortalCommentsPageByObjectIdResponse(id=1059261, encodeId=546f10592612b, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：胃肠 经验分享：6月投，7月大修，9月修回。然后一定要让签署electric copyright,可惜这个electric copyright只发给了第一作者，没有发给通讯作者，然后通讯作者一直接收不到，而第一作者转发给通讯作者的电子版权协议，因为已经点击过，就没办法再点击，然后就一直耽误着，出版社说发了几次了，但始终没有接收到是怎么回事？通讯作者是hotmail的邮箱。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=33f45280010, createdName=1483f2a9m06(暂无昵称), createdTime=Sun Oct 10 21:39:44 CST 2021, time=2021-10-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1184498, encodeId=2504118449814, content=想问一下这个copyright license agreement 要五天之内提交但是并没有提交按钮还是说所有作者只要点击了accept就可以了然后和修改的文章14天之内提交上就好呀谢谢大家, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a3085595427, createdName=ms2000000810824338, createdTime=Sat Jan 15 09:01:15 CST 2022, time=2022-01-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2107181, encodeId=0d7c210e181e0, content=审稿速度:2.0 | 投稿命中率:95.0 偏重的研究方向：肿瘤 经验分享：已接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d8022567422, createdName=12576f0em36暂无昵称, createdTime=Fri Dec 23 18:31:42 CST 2022, time=2022-12-23, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2112349, encodeId=ea04211234942, content=我就想知道有没有被拒稿的😢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=abdf8259299, createdName=ms5000001962513562, createdTime=Tue Jan 31 10:11:43 CST 2023, time=2023-01-31, status=1, ipAttribution=浙江省)]

2021-10-10 1483f2a9m06(暂无昵称)

审稿速度:1.0 | 投稿命中率:75.0
偏重的研究方向：胃肠
经验分享：6月投，7月大修，9月修回。然后一定要让签署electric copyright,可惜这个electric copyright只发给了第一作者，没有发给通讯作者，然后通讯作者一直接收不到，而第一作者转发给通讯作者的电子版权协议，因为已经点击过，就没办法再点击，然后就一直耽误着，出版社说发了几次了，但始终没有接收到是怎么回事？通讯作者是hotmail的邮箱。

94 11

展开11条回复

[GetPortalCommentsPageByObjectIdResponse(id=2168901, encodeId=d6e021689019d, content=审稿速度:3.0 | 投稿命中率:75.0 经验分享：比较容易中，小修一次就接受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ec578253286, createdName=ms5000000127745421, createdTime=Thu Nov 16 20:46:10 CST 2023, time=2023-11-16, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=1221311, encodeId=6078122131175, content=审稿速度:12.0 | 投稿命中率:75.0 偏重的研究方向：心血管疾病个案报道 经验分享：垃圾杂志，外审速度极快，1周结果全部回来，1个月后编辑发回修改，然后在科学编辑那滞留了4个月没动静，中间催稿无数次无效，且不给正式接收函，最后找杂志总编辑投诉安排校稿了，然后又经过1个月的强硬催稿才发接收函。投稿应该是相对很容易中的，但是中危预警，版面费又奇高2250美元，医院很可能不给报销。且投稿要求文件很多，准备很麻烦，必须有润色证明，并且达到A级。慎投！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=921d4775210, createdName=doctorsu1101, createdTime=Sat May 21 00:11:09 CST 2022, time=2022-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=908770, encodeId=7ab5908e7084, content=请问是不可以共一吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=127, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4d925444931, createdName=ms8000001517694171, createdTime=Thu Dec 17 08:18:20 CST 2020, time=2020-12-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1206855, encodeId=b1701206855d2, content=上周周末汇版面费，今天发现银行那边收取15美元的手续费，我是该后期补交这个手续费么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=91395727558, createdName=ms8000001964189397, createdTime=Tue Mar 29 11:01:50 CST 2022, time=2022-03-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2147516, encodeId=c332214e51636, content=期刊名称：World Journal of Clinical Cases 影响因子：1.1 JCR分区：Q4 中科院分区：医学4区 小类：医学：内科4区 OPEN ACCESS：不清楚 出版周期：暂无数据 是否综述：否 预警等级：2023年中科院中风险预警（2021年中风险），多地黑名单预警（2023江苏省肿瘤医院中危预警、2023年度北京301医院预警、长江大学中风险预警、2022复旦大学附属华山医院不鼓励投稿预警期刊、上海市第一人民医院预警） 无视预警的单位果断投，每年收几千篇文章，属于比较好中的，速度也快，就是投稿过程比较繁琐，本人3月投的文章，6月底接收，不影响明年毕业~ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e9c968577, createdName=lunasanger, createdTime=Tue Jul 11 19:16:22 CST 2023, time=2023-07-11, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2145331, encodeId=18f421453310f, content=审稿速度:2.0 | 投稿命中率:95.0 偏重的研究方向：病例报道;肿瘤 经验分享：竟然影响因子也有1.1分, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/Random/55971dc507c93968175ce7cc1e177b372a83869f.jpg, createdBy=f63e4754896, createdName=侠胆医心, createdTime=Thu Jun 29 05:40:19 CST 2023, time=2023-06-29, status=1, ipAttribution=香港), GetPortalCommentsPageByObjectIdResponse(id=1059261, encodeId=546f10592612b, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：胃肠 经验分享：6月投，7月大修，9月修回。然后一定要让签署electric copyright,可惜这个electric copyright只发给了第一作者，没有发给通讯作者，然后通讯作者一直接收不到，而第一作者转发给通讯作者的电子版权协议，因为已经点击过，就没办法再点击，然后就一直耽误着，出版社说发了几次了，但始终没有接收到是怎么回事？通讯作者是hotmail的邮箱。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=33f45280010, createdName=1483f2a9m06(暂无昵称), createdTime=Sun Oct 10 21:39:44 CST 2021, time=2021-10-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1184498, encodeId=2504118449814, content=想问一下这个copyright license agreement 要五天之内提交但是并没有提交按钮还是说所有作者只要点击了accept就可以了然后和修改的文章14天之内提交上就好呀谢谢大家, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a3085595427, createdName=ms2000000810824338, createdTime=Sat Jan 15 09:01:15 CST 2022, time=2022-01-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2107181, encodeId=0d7c210e181e0, content=审稿速度:2.0 | 投稿命中率:95.0 偏重的研究方向：肿瘤 经验分享：已接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d8022567422, createdName=12576f0em36暂无昵称, createdTime=Fri Dec 23 18:31:42 CST 2022, time=2022-12-23, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2112349, encodeId=ea04211234942, content=我就想知道有没有被拒稿的😢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=abdf8259299, createdName=ms5000001962513562, createdTime=Tue Jan 31 10:11:43 CST 2023, time=2023-01-31, status=1, ipAttribution=浙江省)]

2022-01-15 ms2000000810824338

想问一下这个copyright license agreement 要五天之内提交但是并没有提交按钮还是说所有作者只要点击了accept就可以了然后和修改的文章14天之内提交上就好呀谢谢大家

1 4

展开4条回复

[GetPortalCommentsPageByObjectIdResponse(id=2168901, encodeId=d6e021689019d, content=审稿速度:3.0 | 投稿命中率:75.0 经验分享：比较容易中，小修一次就接受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ec578253286, createdName=ms5000000127745421, createdTime=Thu Nov 16 20:46:10 CST 2023, time=2023-11-16, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=1221311, encodeId=6078122131175, content=审稿速度:12.0 | 投稿命中率:75.0 偏重的研究方向：心血管疾病个案报道 经验分享：垃圾杂志，外审速度极快，1周结果全部回来，1个月后编辑发回修改，然后在科学编辑那滞留了4个月没动静，中间催稿无数次无效，且不给正式接收函，最后找杂志总编辑投诉安排校稿了，然后又经过1个月的强硬催稿才发接收函。投稿应该是相对很容易中的，但是中危预警，版面费又奇高2250美元，医院很可能不给报销。且投稿要求文件很多，准备很麻烦，必须有润色证明，并且达到A级。慎投！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=921d4775210, createdName=doctorsu1101, createdTime=Sat May 21 00:11:09 CST 2022, time=2022-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=908770, encodeId=7ab5908e7084, content=请问是不可以共一吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=127, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4d925444931, createdName=ms8000001517694171, createdTime=Thu Dec 17 08:18:20 CST 2020, time=2020-12-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1206855, encodeId=b1701206855d2, content=上周周末汇版面费，今天发现银行那边收取15美元的手续费，我是该后期补交这个手续费么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=91395727558, createdName=ms8000001964189397, createdTime=Tue Mar 29 11:01:50 CST 2022, time=2022-03-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2147516, encodeId=c332214e51636, content=期刊名称：World Journal of Clinical Cases 影响因子：1.1 JCR分区：Q4 中科院分区：医学4区 小类：医学：内科4区 OPEN ACCESS：不清楚 出版周期：暂无数据 是否综述：否 预警等级：2023年中科院中风险预警（2021年中风险），多地黑名单预警（2023江苏省肿瘤医院中危预警、2023年度北京301医院预警、长江大学中风险预警、2022复旦大学附属华山医院不鼓励投稿预警期刊、上海市第一人民医院预警） 无视预警的单位果断投，每年收几千篇文章，属于比较好中的，速度也快，就是投稿过程比较繁琐，本人3月投的文章，6月底接收，不影响明年毕业~ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e9c968577, createdName=lunasanger, createdTime=Tue Jul 11 19:16:22 CST 2023, time=2023-07-11, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2145331, encodeId=18f421453310f, content=审稿速度:2.0 | 投稿命中率:95.0 偏重的研究方向：病例报道;肿瘤 经验分享：竟然影响因子也有1.1分, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/Random/55971dc507c93968175ce7cc1e177b372a83869f.jpg, createdBy=f63e4754896, createdName=侠胆医心, createdTime=Thu Jun 29 05:40:19 CST 2023, time=2023-06-29, status=1, ipAttribution=香港), GetPortalCommentsPageByObjectIdResponse(id=1059261, encodeId=546f10592612b, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：胃肠 经验分享：6月投，7月大修，9月修回。然后一定要让签署electric copyright,可惜这个electric copyright只发给了第一作者，没有发给通讯作者，然后通讯作者一直接收不到，而第一作者转发给通讯作者的电子版权协议，因为已经点击过，就没办法再点击，然后就一直耽误着，出版社说发了几次了，但始终没有接收到是怎么回事？通讯作者是hotmail的邮箱。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=33f45280010, createdName=1483f2a9m06(暂无昵称), createdTime=Sun Oct 10 21:39:44 CST 2021, time=2021-10-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1184498, encodeId=2504118449814, content=想问一下这个copyright license agreement 要五天之内提交但是并没有提交按钮还是说所有作者只要点击了accept就可以了然后和修改的文章14天之内提交上就好呀谢谢大家, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a3085595427, createdName=ms2000000810824338, createdTime=Sat Jan 15 09:01:15 CST 2022, time=2022-01-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2107181, encodeId=0d7c210e181e0, content=审稿速度:2.0 | 投稿命中率:95.0 偏重的研究方向：肿瘤 经验分享：已接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d8022567422, createdName=12576f0em36暂无昵称, createdTime=Fri Dec 23 18:31:42 CST 2022, time=2022-12-23, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2112349, encodeId=ea04211234942, content=我就想知道有没有被拒稿的😢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=abdf8259299, createdName=ms5000001962513562, createdTime=Tue Jan 31 10:11:43 CST 2023, time=2023-01-31, status=1, ipAttribution=浙江省)]

2022-12-23 12576f0em36暂无昵称来自四川省

审稿速度:2.0 | 投稿命中率:95.0
偏重的研究方向：肿瘤
经验分享：已接收

67 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2168901, encodeId=d6e021689019d, content=审稿速度:3.0 | 投稿命中率:75.0 经验分享：比较容易中，小修一次就接受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ec578253286, createdName=ms5000000127745421, createdTime=Thu Nov 16 20:46:10 CST 2023, time=2023-11-16, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=1221311, encodeId=6078122131175, content=审稿速度:12.0 | 投稿命中率:75.0 偏重的研究方向：心血管疾病个案报道 经验分享：垃圾杂志，外审速度极快，1周结果全部回来，1个月后编辑发回修改，然后在科学编辑那滞留了4个月没动静，中间催稿无数次无效，且不给正式接收函，最后找杂志总编辑投诉安排校稿了，然后又经过1个月的强硬催稿才发接收函。投稿应该是相对很容易中的，但是中危预警，版面费又奇高2250美元，医院很可能不给报销。且投稿要求文件很多，准备很麻烦，必须有润色证明，并且达到A级。慎投！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=921d4775210, createdName=doctorsu1101, createdTime=Sat May 21 00:11:09 CST 2022, time=2022-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=908770, encodeId=7ab5908e7084, content=请问是不可以共一吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=127, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4d925444931, createdName=ms8000001517694171, createdTime=Thu Dec 17 08:18:20 CST 2020, time=2020-12-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1206855, encodeId=b1701206855d2, content=上周周末汇版面费，今天发现银行那边收取15美元的手续费，我是该后期补交这个手续费么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=91395727558, createdName=ms8000001964189397, createdTime=Tue Mar 29 11:01:50 CST 2022, time=2022-03-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2147516, encodeId=c332214e51636, content=期刊名称：World Journal of Clinical Cases 影响因子：1.1 JCR分区：Q4 中科院分区：医学4区 小类：医学：内科4区 OPEN ACCESS：不清楚 出版周期：暂无数据 是否综述：否 预警等级：2023年中科院中风险预警（2021年中风险），多地黑名单预警（2023江苏省肿瘤医院中危预警、2023年度北京301医院预警、长江大学中风险预警、2022复旦大学附属华山医院不鼓励投稿预警期刊、上海市第一人民医院预警） 无视预警的单位果断投，每年收几千篇文章，属于比较好中的，速度也快，就是投稿过程比较繁琐，本人3月投的文章，6月底接收，不影响明年毕业~ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e9c968577, createdName=lunasanger, createdTime=Tue Jul 11 19:16:22 CST 2023, time=2023-07-11, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2145331, encodeId=18f421453310f, content=审稿速度:2.0 | 投稿命中率:95.0 偏重的研究方向：病例报道;肿瘤 经验分享：竟然影响因子也有1.1分, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/Random/55971dc507c93968175ce7cc1e177b372a83869f.jpg, createdBy=f63e4754896, createdName=侠胆医心, createdTime=Thu Jun 29 05:40:19 CST 2023, time=2023-06-29, status=1, ipAttribution=香港), GetPortalCommentsPageByObjectIdResponse(id=1059261, encodeId=546f10592612b, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：胃肠 经验分享：6月投，7月大修，9月修回。然后一定要让签署electric copyright,可惜这个electric copyright只发给了第一作者，没有发给通讯作者，然后通讯作者一直接收不到，而第一作者转发给通讯作者的电子版权协议，因为已经点击过，就没办法再点击，然后就一直耽误着，出版社说发了几次了，但始终没有接收到是怎么回事？通讯作者是hotmail的邮箱。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=33f45280010, createdName=1483f2a9m06(暂无昵称), createdTime=Sun Oct 10 21:39:44 CST 2021, time=2021-10-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1184498, encodeId=2504118449814, content=想问一下这个copyright license agreement 要五天之内提交但是并没有提交按钮还是说所有作者只要点击了accept就可以了然后和修改的文章14天之内提交上就好呀谢谢大家, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a3085595427, createdName=ms2000000810824338, createdTime=Sat Jan 15 09:01:15 CST 2022, time=2022-01-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2107181, encodeId=0d7c210e181e0, content=审稿速度:2.0 | 投稿命中率:95.0 偏重的研究方向：肿瘤 经验分享：已接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d8022567422, createdName=12576f0em36暂无昵称, createdTime=Fri Dec 23 18:31:42 CST 2022, time=2022-12-23, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2112349, encodeId=ea04211234942, content=我就想知道有没有被拒稿的😢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=abdf8259299, createdName=ms5000001962513562, createdTime=Tue Jan 31 10:11:43 CST 2023, time=2023-01-31, status=1, ipAttribution=浙江省)]

2023-01-31 ms5000001962513562 来自浙江省

我就想知道有没有被拒稿的😢

63 0

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务